Vienna, Austria: – Recombinant protein specialist manufacturer enGenes Biotech GmbH (enGenes) will makes its debut at the second ESIB industrial biotechnology summit in Graz, Austria, next month.
The enGenes team, led by CEO Juergen Mairhofer, will attend the event at the Messecongress Graz conference center to present the company’s latest technologies and the company’s newly designed service portfolio, designed and structured on modular lines.
The service offer provides a wide range of realistic options for companies looking to develop cost-effective manufacturing processes for recombinant proteins.
For more information follow https://www.pharmaceutical-networking.com/engenes-brings-x-press-industrial-biotech-applications-to-esib/
Comentários